Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nuformix Plc ( (GB:NFX) ) has shared an announcement.
Nuformix plc has raised £1.0 million via a placing of 500,000,000 new ordinary shares at 0.20 pence each, with the proceeds earmarked primarily to advance its NXP002 inhaled therapy for idiopathic and progressive pulmonary fibrosis and for general corporate purposes. The funding will support additional targeted pre-clinical studies designed to strengthen the NXP002 programme during ongoing out-licensing and due diligence discussions with potential large pharma and speciality partners, with the new shares expected to be admitted to trading on the London Stock Exchange on or around 17 March 2026, taking total voting rights to 2,609,749,903.
The most recent analyst rating on (GB:NFX) stock is a Sell with a £0.28 price target. To see the full list of analyst forecasts on Nuformix Plc stock, see the GB:NFX Stock Forecast page.
Spark’s Take on GB:NFX Stock
According to Spark, TipRanks’ AI Analyst, GB:NFX is a Neutral.
The score is held down primarily by weak financial performance—zero recent revenue, ongoing losses, and persistent negative free cash flow—despite the benefit of no debt. Technicals add downside risk with price below key short/medium-term averages and negative MACD, while valuation is also constrained by a negative P/E and no dividend support.
To see Spark’s full report on GB:NFX stock, click here.
More about Nuformix Plc
Nuformix plc is a UK-based pharmaceutical development company focused on addressing unmet medical needs in fibrosis and oncology through drug repurposing. Leveraging its expertise in discovering, developing and patenting novel drug forms with improved physical properties, the company aims to create differentiated products in new indications, building a preclinical pipeline with potential for significant value and early licensing deals.
Average Trading Volume: 30,355,731
Technical Sentiment Signal: Hold
Current Market Cap: £6.33M
Learn more about NFX stock on TipRanks’ Stock Analysis page.